Metabolic bone diseases are disorders of bone strength, usually caused by abnormalities of minerals (such as calcium or phosphorus), vitamin D, bone mass or bone structure. The most common metabolic bone disorder is osteoporosis. When untreated, it can lead to fragility fractures, bone deformities and serious disability. Those at high risk for osteoporosis include patients with older age, small body size, history of fractures, steroid use, intestinal diseases, organ transplants and kidney disorders.
Men and women of all ages may suffer from skeletal disorders. The most common include osteoporosis, osteomalacia, Paget’s disease and parathyroid disorders.
The Johns Hopkins Metabolic Bone and Osteoporosis Center brings together the latest in research, technology and patient care to create the best results for each patient. An integrated, multidisciplinary team of experts treats:
- Osteoporosis in men and women
- Steroid-induced osteoporosis
- Chemotherapy-induced bone loss
- Pre-menopausal bone loss
- Fragility and recurrent fractures
- Parathyroid disorders
- Vitamin D deficiency/osteomalacia
- Calcium and phosphorus disorders
- Renal osteodystrophy
- Paget's disease